nodes	percent_of_prediction	percent_of_DWPC	metapath
Isosorbide Mononitrate—Tachycardia—Lisinopril—systemic scleroderma	0.00062	0.00062	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Azathioprine—systemic scleroderma	0.000619	0.000619	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Azathioprine—systemic scleroderma	0.000619	0.000619	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Lisinopril—systemic scleroderma	0.000617	0.000617	CcSEcCtD
Isosorbide Mononitrate—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000615	0.000615	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000614	0.000614	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Captopril—systemic scleroderma	0.000614	0.000614	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000613	0.000613	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000613	0.000613	CcSEcCtD
Isosorbide Mononitrate—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000612	0.000612	CcSEcCtD
Isosorbide Mononitrate—Erectile dysfunction—Prednisone—systemic scleroderma	0.000611	0.000611	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000611	0.000611	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Leflunomide—systemic scleroderma	0.00061	0.00061	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000609	0.000609	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Mycophenolic acid—systemic scleroderma	0.000608	0.000608	CcSEcCtD
Isosorbide Mononitrate—Mood swings—Methotrexate—systemic scleroderma	0.000608	0.000608	CcSEcCtD
Isosorbide Mononitrate—Nausea—Mometasone—systemic scleroderma	0.000607	0.000607	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Lisinopril—systemic scleroderma	0.000606	0.000606	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000605	0.000605	CcSEcCtD
Isosorbide Mononitrate—Weight increased—Prednisone—systemic scleroderma	0.000604	0.000604	CcSEcCtD
Isosorbide Mononitrate—Pain—Mycophenolic acid—systemic scleroderma	0.000603	0.000603	CcSEcCtD
Isosorbide Mononitrate—Constipation—Mycophenolic acid—systemic scleroderma	0.000603	0.000603	CcSEcCtD
Isosorbide Mononitrate—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000603	0.000603	CcSEcCtD
Isosorbide Mononitrate—Weight decreased—Prednisone—systemic scleroderma	0.000601	0.000601	CcSEcCtD
Isosorbide Mononitrate—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.0006	0.0006	CcSEcCtD
Isosorbide Mononitrate—Cough—Mycophenolate mofetil—systemic scleroderma	0.000595	0.000595	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Lisinopril—systemic scleroderma	0.000594	0.000594	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Captopril—systemic scleroderma	0.000594	0.000594	CcSEcCtD
Isosorbide Mononitrate—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000589	0.000589	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Leflunomide—systemic scleroderma	0.000585	0.000585	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Leflunomide—systemic scleroderma	0.000585	0.000585	CcSEcCtD
Isosorbide Mononitrate—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000584	0.000584	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000582	0.000582	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000581	0.000581	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000581	0.000581	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000581	0.000581	CcSEcCtD
Isosorbide Mononitrate—Myocardial infarction—Prednisone—systemic scleroderma	0.00058	0.00058	CcSEcCtD
Isosorbide Mononitrate—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00058	0.00058	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000579	0.000579	CcSEcCtD
Isosorbide Mononitrate—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000579	0.000579	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Azathioprine—systemic scleroderma	0.000577	0.000577	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000577	0.000577	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Lisinopril—systemic scleroderma	0.000575	0.000575	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000574	0.000574	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Lisinopril—systemic scleroderma	0.000571	0.000571	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Captopril—systemic scleroderma	0.000571	0.000571	CcSEcCtD
Isosorbide Mononitrate—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000568	0.000568	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Lisinopril—systemic scleroderma	0.000567	0.000567	CcSEcCtD
Isosorbide Mononitrate—Rash—Captopril—systemic scleroderma	0.000566	0.000566	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Captopril—systemic scleroderma	0.000565	0.000565	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Lisinopril—systemic scleroderma	0.000565	0.000565	CcSEcCtD
Isosorbide Mononitrate—Headache—Captopril—systemic scleroderma	0.000562	0.000562	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000562	0.000562	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Lisinopril—systemic scleroderma	0.00056	0.00056	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000558	0.000558	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000558	0.000558	CcSEcCtD
Isosorbide Mononitrate—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000557	0.000557	CcSEcCtD
Isosorbide Mononitrate—Asthma—Methotrexate—systemic scleroderma	0.000555	0.000555	CcSEcCtD
Isosorbide Mononitrate—Infection—Mycophenolate mofetil—systemic scleroderma	0.000553	0.000553	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Lisinopril—systemic scleroderma	0.000553	0.000553	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000549	0.000549	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Lisinopril—systemic scleroderma	0.000548	0.000548	CcSEcCtD
Isosorbide Mononitrate—Shock—Mycophenolate mofetil—systemic scleroderma	0.000548	0.000548	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000546	0.000546	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000545	0.000545	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Leflunomide—systemic scleroderma	0.000545	0.000545	CcSEcCtD
Isosorbide Mononitrate—Constipation—Lisinopril—systemic scleroderma	0.000544	0.000544	CcSEcCtD
Isosorbide Mononitrate—Pain—Lisinopril—systemic scleroderma	0.000544	0.000544	CcSEcCtD
Isosorbide Mononitrate—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000544	0.000544	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000541	0.000541	CcSEcCtD
Isosorbide Mononitrate—Bradycardia—Prednisone—systemic scleroderma	0.000541	0.000541	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000538	0.000538	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Azathioprine—systemic scleroderma	0.000536	0.000536	CcSEcCtD
Isosorbide Mononitrate—Haemoglobin—Prednisone—systemic scleroderma	0.000534	0.000534	CcSEcCtD
Isosorbide Mononitrate—Nausea—Captopril—systemic scleroderma	0.000533	0.000533	CcSEcCtD
Isosorbide Mononitrate—Haemorrhage—Prednisone—systemic scleroderma	0.000531	0.000531	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000531	0.000531	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Leflunomide—systemic scleroderma	0.000531	0.000531	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Lisinopril—systemic scleroderma	0.000524	0.000524	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Leflunomide—systemic scleroderma	0.000523	0.000523	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00052	0.00052	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00052	0.00052	CcSEcCtD
Isosorbide Mononitrate—Dysuria—Methotrexate—systemic scleroderma	0.000519	0.000519	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Azathioprine—systemic scleroderma	0.000518	0.000518	CcSEcCtD
Isosorbide Mononitrate—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000516	0.000516	CcSEcCtD
Isosorbide Mononitrate—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000511	0.000511	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000507	0.000507	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Mycophenolic acid—systemic scleroderma	0.000506	0.000506	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Leflunomide—systemic scleroderma	0.000506	0.000506	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000504	0.000504	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Lisinopril—systemic scleroderma	0.000502	0.000502	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Lisinopril—systemic scleroderma	0.000502	0.000502	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.0005	0.0005	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Mycophenolic acid—systemic scleroderma	0.000499	0.000499	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Azathioprine—systemic scleroderma	0.000498	0.000498	CcSEcCtD
Isosorbide Mononitrate—Pneumonia—Methotrexate—systemic scleroderma	0.000498	0.000498	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000497	0.000497	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000495	0.000495	CcSEcCtD
Isosorbide Mononitrate—Rash—Azathioprine—systemic scleroderma	0.000494	0.000494	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Azathioprine—systemic scleroderma	0.000493	0.000493	CcSEcCtD
Isosorbide Mononitrate—Flushing—Prednisone—systemic scleroderma	0.000493	0.000493	CcSEcCtD
Isosorbide Mononitrate—Headache—Azathioprine—systemic scleroderma	0.000491	0.000491	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00049	0.00049	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Leflunomide—systemic scleroderma	0.000489	0.000489	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000484	0.000484	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000483	0.000483	CcSEcCtD
Isosorbide Mononitrate—Conjunctivitis—Methotrexate—systemic scleroderma	0.000481	0.000481	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000481	0.000481	CcSEcCtD
Isosorbide Mononitrate—Pain—Mycophenolate mofetil—systemic scleroderma	0.000476	0.000476	CcSEcCtD
Isosorbide Mononitrate—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000476	0.000476	CcSEcCtD
Isosorbide Mononitrate—Arrhythmia—Prednisone—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Isosorbide Mononitrate—Sweating—Methotrexate—systemic scleroderma	0.000474	0.000474	CcSEcCtD
Isosorbide Mononitrate—Haematuria—Methotrexate—systemic scleroderma	0.000472	0.000472	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Leflunomide—systemic scleroderma	0.00047	0.00047	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Lisinopril—systemic scleroderma	0.000468	0.000468	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Mycophenolic acid—systemic scleroderma	0.000467	0.000467	CcSEcCtD
Isosorbide Mononitrate—Epistaxis—Methotrexate—systemic scleroderma	0.000467	0.000467	CcSEcCtD
Isosorbide Mononitrate—Rash—Leflunomide—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Leflunomide—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Isosorbide Mononitrate—Mental disorder—Prednisone—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Isosorbide Mononitrate—Nausea—Azathioprine—systemic scleroderma	0.000465	0.000465	CcSEcCtD
Isosorbide Mononitrate—Headache—Leflunomide—systemic scleroderma	0.000463	0.000463	CcSEcCtD
Isosorbide Mononitrate—Malnutrition—Prednisone—systemic scleroderma	0.000463	0.000463	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000459	0.000459	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Lisinopril—systemic scleroderma	0.000456	0.000456	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000455	0.000455	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Lisinopril—systemic scleroderma	0.00045	0.00045	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Mycophenolic acid—systemic scleroderma	0.000449	0.000449	CcSEcCtD
Isosorbide Mononitrate—Haemoglobin—Methotrexate—systemic scleroderma	0.000446	0.000446	CcSEcCtD
Isosorbide Mononitrate—Rash—Mycophenolic acid—systemic scleroderma	0.000445	0.000445	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000445	0.000445	CcSEcCtD
Isosorbide Mononitrate—Haemorrhage—Methotrexate—systemic scleroderma	0.000444	0.000444	CcSEcCtD
Isosorbide Mononitrate—Headache—Mycophenolic acid—systemic scleroderma	0.000442	0.000442	CcSEcCtD
Isosorbide Mononitrate—Pharyngitis—Methotrexate—systemic scleroderma	0.000441	0.000441	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Isosorbide Mononitrate—Nausea—Leflunomide—systemic scleroderma	0.000439	0.000439	CcSEcCtD
Isosorbide Mononitrate—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000439	0.000439	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Prednisone—systemic scleroderma	0.000436	0.000436	CcSEcCtD
Isosorbide Mononitrate—Urethral disorder—Methotrexate—systemic scleroderma	0.000435	0.000435	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Lisinopril—systemic scleroderma	0.000435	0.000435	CcSEcCtD
Isosorbide Mononitrate—Ill-defined disorder—Prednisone—systemic scleroderma	0.000429	0.000429	CcSEcCtD
Isosorbide Mononitrate—Visual impairment—Methotrexate—systemic scleroderma	0.000428	0.000428	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Prednisone—systemic scleroderma	0.000428	0.000428	CcSEcCtD
Isosorbide Mononitrate—Agitation—Prednisone—systemic scleroderma	0.000425	0.000425	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Lisinopril—systemic scleroderma	0.00042	0.00042	CcSEcCtD
Isosorbide Mononitrate—Nausea—Mycophenolic acid—systemic scleroderma	0.000419	0.000419	CcSEcCtD
Isosorbide Mononitrate—Malaise—Prednisone—systemic scleroderma	0.000417	0.000417	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Prednisone—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Isosorbide Mononitrate—Syncope—Prednisone—systemic scleroderma	0.000415	0.000415	CcSEcCtD
Isosorbide Mononitrate—Tinnitus—Methotrexate—systemic scleroderma	0.000414	0.000414	CcSEcCtD
Isosorbide Mononitrate—Cardiac disorder—Methotrexate—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00041	0.00041	CcSEcCtD
Isosorbide Mononitrate—Loss of consciousness—Prednisone—systemic scleroderma	0.000407	0.000407	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Lisinopril—systemic scleroderma	0.000404	0.000404	CcSEcCtD
Isosorbide Mononitrate—Rash—Lisinopril—systemic scleroderma	0.000401	0.000401	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Lisinopril—systemic scleroderma	0.0004	0.0004	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.0004	0.0004	CcSEcCtD
Isosorbide Mononitrate—Hypertension—Prednisone—systemic scleroderma	0.000399	0.000399	CcSEcCtD
Isosorbide Mononitrate—Chills—Methotrexate—systemic scleroderma	0.000398	0.000398	CcSEcCtD
Isosorbide Mononitrate—Headache—Lisinopril—systemic scleroderma	0.000398	0.000398	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000394	0.000394	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Prednisone—systemic scleroderma	0.000394	0.000394	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Prednisone—systemic scleroderma	0.000394	0.000394	CcSEcCtD
Isosorbide Mononitrate—Anxiety—Prednisone—systemic scleroderma	0.000392	0.000392	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Prednisone—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Isosorbide Mononitrate—Mental disorder—Methotrexate—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Isosorbide Mononitrate—Malnutrition—Methotrexate—systemic scleroderma	0.000387	0.000387	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000381	0.000381	CcSEcCtD
Isosorbide Mononitrate—Dysgeusia—Methotrexate—systemic scleroderma	0.000379	0.000379	CcSEcCtD
Isosorbide Mononitrate—Nausea—Lisinopril—systemic scleroderma	0.000378	0.000378	CcSEcCtD
Isosorbide Mononitrate—Oedema—Prednisone—systemic scleroderma	0.000378	0.000378	CcSEcCtD
Isosorbide Mononitrate—Infection—Prednisone—systemic scleroderma	0.000375	0.000375	CcSEcCtD
Isosorbide Mononitrate—Back pain—Methotrexate—systemic scleroderma	0.000374	0.000374	CcSEcCtD
Isosorbide Mononitrate—Shock—Prednisone—systemic scleroderma	0.000371	0.000371	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Prednisone—systemic scleroderma	0.00037	0.00037	CcSEcCtD
Isosorbide Mononitrate—Tachycardia—Prednisone—systemic scleroderma	0.000368	0.000368	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000368	0.000368	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Prednisone—systemic scleroderma	0.000367	0.000367	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Prednisone—systemic scleroderma	0.000365	0.000365	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Methotrexate—systemic scleroderma	0.000364	0.000364	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Prednisone—systemic scleroderma	0.00036	0.00036	CcSEcCtD
Isosorbide Mononitrate—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000359	0.000359	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Methotrexate—systemic scleroderma	0.000357	0.000357	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000354	0.000354	CcSEcCtD
Isosorbide Mononitrate—Rash—Mycophenolate mofetil—systemic scleroderma	0.000351	0.000351	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000351	0.000351	CcSEcCtD
Isosorbide Mononitrate—Headache—Mycophenolate mofetil—systemic scleroderma	0.000349	0.000349	CcSEcCtD
Isosorbide Mononitrate—Malaise—Methotrexate—systemic scleroderma	0.000349	0.000349	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Methotrexate—systemic scleroderma	0.000347	0.000347	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Methotrexate—systemic scleroderma	0.000346	0.000346	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000344	0.000344	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Prednisone—systemic scleroderma	0.000341	0.000341	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Prednisone—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Isosorbide Mononitrate—Cough—Methotrexate—systemic scleroderma	0.000337	0.000337	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Prednisone—systemic scleroderma	0.000332	0.000332	CcSEcCtD
Isosorbide Mononitrate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000331	0.000331	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Methotrexate—systemic scleroderma	0.000329	0.000329	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Methotrexate—systemic scleroderma	0.000329	0.000329	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Methotrexate—systemic scleroderma	0.000329	0.000329	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Prednisone—systemic scleroderma	0.000328	0.000328	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Prednisone—systemic scleroderma	0.000325	0.000325	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Methotrexate—systemic scleroderma	0.000325	0.000325	CcSEcCtD
Isosorbide Mononitrate—Constipation—Prednisone—systemic scleroderma	0.000323	0.000323	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Methotrexate—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Isosorbide Mononitrate—Infection—Methotrexate—systemic scleroderma	0.000313	0.000313	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Prednisone—systemic scleroderma	0.000311	0.000311	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Methotrexate—systemic scleroderma	0.000309	0.000309	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000309	0.000309	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000309	0.000309	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Methotrexate—systemic scleroderma	0.000306	0.000306	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000305	0.000305	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Methotrexate—systemic scleroderma	0.000301	0.000301	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Prednisone—systemic scleroderma	0.000298	0.000298	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Prednisone—systemic scleroderma	0.000298	0.000298	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Methotrexate—systemic scleroderma	0.000295	0.000295	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Methotrexate—systemic scleroderma	0.000285	0.000285	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Methotrexate—systemic scleroderma	0.000283	0.000283	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Methotrexate—systemic scleroderma	0.000281	0.000281	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Methotrexate—systemic scleroderma	0.00028	0.00028	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Prednisone—systemic scleroderma	0.000278	0.000278	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Methotrexate—systemic scleroderma	0.000278	0.000278	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Methotrexate—systemic scleroderma	0.000274	0.000274	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000272	0.000272	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Methotrexate—systemic scleroderma	0.000272	0.000272	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Prednisone—systemic scleroderma	0.000271	0.000271	CcSEcCtD
Isosorbide Mononitrate—Pain—Methotrexate—systemic scleroderma	0.00027	0.00027	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Prednisone—systemic scleroderma	0.000267	0.000267	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Methotrexate—systemic scleroderma	0.00026	0.00026	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Prednisone—systemic scleroderma	0.000258	0.000258	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000258	0.000258	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Prednisone—systemic scleroderma	0.00025	0.00025	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Methotrexate—systemic scleroderma	0.000249	0.000249	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Methotrexate—systemic scleroderma	0.000249	0.000249	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Prednisone—systemic scleroderma	0.00024	0.00024	CcSEcCtD
Isosorbide Mononitrate—Rash—Prednisone—systemic scleroderma	0.000238	0.000238	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Prednisone—systemic scleroderma	0.000238	0.000238	CcSEcCtD
Isosorbide Mononitrate—Headache—Prednisone—systemic scleroderma	0.000237	0.000237	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Methotrexate—systemic scleroderma	0.000232	0.000232	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Methotrexate—systemic scleroderma	0.000226	0.000226	CcSEcCtD
Isosorbide Mononitrate—Nausea—Prednisone—systemic scleroderma	0.000224	0.000224	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Methotrexate—systemic scleroderma	0.000223	0.000223	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Methotrexate—systemic scleroderma	0.000216	0.000216	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Methotrexate—systemic scleroderma	0.000209	0.000209	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Methotrexate—systemic scleroderma	0.000201	0.000201	CcSEcCtD
Isosorbide Mononitrate—Rash—Methotrexate—systemic scleroderma	0.000199	0.000199	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Methotrexate—systemic scleroderma	0.000199	0.000199	CcSEcCtD
Isosorbide Mononitrate—Headache—Methotrexate—systemic scleroderma	0.000198	0.000198	CcSEcCtD
Isosorbide Mononitrate—Nausea—Methotrexate—systemic scleroderma	0.000187	0.000187	CcSEcCtD
